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behavior and failure patterns in H&N may 
be different from trunk/extremity, supporting 
consideration of dedicated H&N trial. 
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and increases risk for encephalopathy.1,2 
Thiamine supplementation for patients with 
encephalopathy has become routine at UNMC 
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hypothesized that thiamine supplementation 
in hospitalized patients with encephalopathy 
would decrease their length of stay (LOS).
Methods: Adults (age >19 years) with index 
admission to UNMC between 1/1/2017 and 
12/31/2017, hospital stay of 3-30 days, and 
ICD-10 code associated with encephalopathy 
	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	
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health record data access core. Primary 
outcome was hospital LOS, which we log-
transformed due to skewness. Model adjusted 
mean log LOS estimates were exponentiated 
to obtain geometric means. Patients in 
the Thiamine group received at least one 
dose of supplemental thiamine (including 
multivitamins). A general linear model was 
used to evaluate the association between log 
LOS and thiamine supplementation.
Results: 		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met the above criteria. Table 1 describes 
the cohort demographics and clinical 
characteristics. After adjusting for potential 
confounding variables (denoted in Table 1), 
the mean log LOS was 1.95 for the Thiamine 
group and 1.63 for the No Thiamine group (p 
<0.0001). 
Table 1.
+SLN group demonstrates higher rate of local (LR), nodal (LNR), and systemic (SR) recurrence, as 
well as higher rate of death due to disease (DOD) when compared with -SLN group. Within +SLN 
group, patients who underwent complete lymph node dissection (CLND) surprisingly have higher rate 
of LR, LNR, SR, and DOD. 
Completed SLNBx  
(N= 108)
LR % LNR % Local/Regional 
recurrence %
SR % Combined 
Sys/Nodal %
DOD % NED %











































Age (mean ± SD)* 66.5 ± 18.1 59.4 ± 15.5 <0.0001a
Gender* 0.0004
Female 67 (37.6) 423 (52.4)
Male 111 (62.4) 384 (47.6)
Race 0.47
Black 32 (18.4) 119 (14.8)
White 129 (74.1) 627 (78.1)
Other 13 (7.5) 57 (7.1)
Ethnicity 0.65
Hispanic 8 (4.5) 43 (5.3)
Not Hispanic 170 (95.5) 763 (94.7)
Work status  <0.0001
Disabled 44 (25.1) 166 (20.7)
Employed/Student/Retired 81 (46.3) 524 (65.3)
Not employed 50 (28.6) 112 (14.0)
Insurance status* 0.004
Insured 151 (84.8) 741 (91.8)
Not insured 27 (15.2) 66 (8.2)
Clinical Characteristics
Log (DRG weight) (mean ± SD) 0.43 ± 0.64 0.26 ± 0.53 0.001a
Alcohol use* 68 (51.9) 166 (26.0) <0.0001
PMH of malabsorption 20 (11.2) 115 (14.3) 0.29
PMH of GI disease 22 (12.4) 113 (14.0) 0.56
PMH of malnutrition* 46 (25.8) 167 (20.7) 0.13
PMH of cancer 40 (22.5) 220 (27.3) 0.19
PMH of GI surgery 28 (15.7) 98 (12.1) 0.19
Home use of loop diuretics 4 (2.2) 17 (2.1) 0.78b
Home use of PPIs 1 (0.6) 17 (2.1) 0.22b
Sepsis during hospital stay* 46 (25.8) 193 (23.9) 0.59
DKA during hospital stay* 27 (15.2) 72 (8.9) 0.01
Neurology service consulted* 57 (32.0) 141 (17.5) <0.0001
Outcomes
Log (Length of stay) (mean ± SD) 1.98 ± 0.70 1.60 ± 0.60 <0.0001a
Abbreviations: SD = standard deviation. DRG = 
diagnosis-related group. PMH = past medical history. 
GI = gastrointestinal. DKA = diabetic ketoacidosis. LOS 
= length of stay.
P-values from Chi-Square tests, unless otherwise 
	 
a P-values from t-test. 
b P-values from Fisher’s exact test. 
* Potential confounding variables that can contribute to 
log (LOS) via linear model.
Demographic information, clinical characteristics, 
and primary outcome were compared between the 
Thiamine group and No Thiamine group. 
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Conclusion: Contrary to prevailing 
expectations and our study hypothesis, we 
found that thiamine supplementation in 
hospitalized patients with encephalopathy 
did not improve LOS. Our results are 
							
of supplemental thiamine in other disease 
conditions such as sepsis (VITAMINS study) 
and congestive heart failure.3-5 We do not 
recommend routine thiamine supplementation 
in hospitalized patients. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.033
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Introduction: There are few cases of non-
diverticulitis episodes of colonic perforation 
following kidney transplantation throughout 
literature. In the systematic literature review 
by de’Angelis et al, emergency abdominal 
surgery following solid organ transplantation 
for non-diverticulitis causes gastrointestinal 
perforation accounts of 9.2% of cases, and 
about 58% of those perforations occurred 
in the colon. The aim of this case series is 
to review the events surrounding our two 
cases of colonic perforation following renal 
transplantation in hopes to gain understanding 
of this rare occurrence. Consent was obtained 
from the patients.
Case: Since 2011, there have been two 
events of transverse colonic perforation in the 
acute post-operative period following renal 
transplantation occurring at this institution. 





symptoms prompted urgent surgical 
intervention in both cases. Both patients 
underwent urgent exploratory laparotomy 
and Hartmann procedure with resection of 
perforated transverse colon and proximal 
	*		
			
takedown and primary colonic re-anastomosis 
about one year after his kidney transplant. 
The second patient is currently scheduled for 
future colostomy reversal. 
Conclusion: Various theories of non-
diverticular causes of colonic perforations 
are described in literature including 
cytomegalovirus enterocolitis, uremic 
enterocolitis, fecal impaction, and 
corticosteroid administration among others. 
Despite the lack of clear cause of perforation, 
it is imperative to have a high index of 
suspicion for these immunocompromised 
patients for prompt surgical treatment. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.034
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Background: Adequate control of bleeding 
during spine surgery is paramount to the 
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Tranexamic acid (TXA) is a systemic 
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blood loss during various orthopaedic 
procedures. TXA’s role in posterior cervical 
spinal surgery, however, remains poorly 
described. Therefore we sought to evaluate 
whether prophylactic TXA administration 
prior to posterior cervical fusion reduces 
perioperative blood loss and mean operative 
time.
Methods: Patients undergoing three to 
six-level posterior cervical fusions were 
retrospectively enrolled into two groups. In 
the study group, 21 patients received TXA 
prior to surgery, and in the control group, 
21 patients did not. Patient’s younger than 
19 years old, and those undergoing surgery 
for infection or tumors were excluded. 
Intraoperative blood loss, operative time, and 
postoperative drain output were measured in 
addition to demographic data.
Results: No difference existed between 
groups in regards to demographics. The 
study group had a lower mean operative 
time (94 min) vs the control group (110 
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+				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(p=0.06071). Postoperative day 1 drain output 
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(p<0.0239). Intraoperative blood loss, day 
2, 3 and total drain output were lower in the 
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There were two postoperative hematomas 
in the control group. No postoperative 
thromboembolic events occurred in either 
group. 
